{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:59:29Z","timestamp":1790276369975,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32090052"],"award-info":[{"award-number":["32090052"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20250604182535045"],"award-info":[{"award-number":["JCYJ20250604182535045"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20240813143215019"],"award-info":[{"award-number":["JCYJ20240813143215019"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.intimp.2026.117386","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:59:18Z","timestamp":1788951558000},"page":"117386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Metabolic\u2013epigenetic reprogramming of airway fibroblasts by K\u00a0+\u00a0N therapy suppresses IL-33 and ameliorates allergic asthma"],"prefix":"10.1016","volume":"189","author":[{"given":"Xiangdong","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingchang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.intimp.2026.117386_bb0005","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S2213-2600(24)00383-7","article-title":"Asthma: epidemiology, risk factors, and opportunities for prevention and treatment","volume":"13","author":"Jayasooriya","year":"2025","journal-title":"Lancet Respir. Med."},{"issue":"6","key":"10.1016\/j.intimp.2026.117386_bb0010","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jaci.2021.10.001","article-title":"Advances in asthma: new understandings of asthma's natural history, risk factors, underlying mechanisms, and clinical management","volume":"148","author":"Miller","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117386_bb0015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaci.2024.10.024","article-title":"Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype","volume":"155","author":"Domvri","year":"2025","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117386_bb0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/jama.2024.22700","article-title":"Inhaled reliever therapies for asthma: a systematic review and Meta-analysis","volume":"333","author":"Rayner","year":"2025","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.intimp.2026.117386_bb0025","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/14712598.2024.2342527","article-title":"Advancements in biologic therapy in eosinophilic asthma","volume":"24","author":"Patadia","year":"2024","journal-title":"Expert Opin. Biol. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2026.117386_bb0030","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/17425255.2023.2230130","article-title":"Pharmacokinetic considerations surrounding triple therapy for uncontrolled asthma","volume":"19","author":"Matera","year":"2023","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117386_bb0035","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01619-2023","article-title":"Airway remodelling in asthma and the epithelium: on the edge of a new era","volume":"63","author":"Varricchi","year":"2024","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.intimp.2026.117386_bb0040","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01326-2023","article-title":"Sfrp1 inhibits lung fibroblast invasion during transition to injury-induced myofibroblasts","volume":"63","author":"Mayr","year":"2024","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.intimp.2026.117386_bb0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.smim.2017.11.001","article-title":"A short field guide to fibroblast function in immunity","volume":"35","author":"Buechler","year":"2018","journal-title":"Semin. Immunol."},{"issue":"28","key":"10.1016\/j.intimp.2026.117386_bb0050","doi-asserted-by":"crossref","first-page":"eaba1983","DOI":"10.1126\/sciadv.aba1983","article-title":"Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis","volume":"6","author":"Adams","year":"2020","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.intimp.2026.117386_bb0055","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1186\/s12967-023-04782-4","article-title":"Role of IL-33-ST2 pathway in regulating inflammation: current evidence and future perspectives","volume":"21","author":"Zhou","year":"2023","journal-title":"J. Transl. Med."},{"issue":"29","key":"10.1016\/j.intimp.2026.117386_bb0060","doi-asserted-by":"crossref","first-page":"eadi4862","DOI":"10.1126\/sciadv.adi4862","article-title":"What is really known about the effects of nicotinamide riboside supplementation in humans","volume":"9","author":"Damgaard","year":"2023","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.intimp.2026.117386_bb0065","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202503552","article-title":"Dectin-1 epigenetic reprogramming rescues senescent-like Treg function in allergic asthma","volume":"9","author":"Sun","year":"2026","journal-title":"Life Sci Alliance"},{"issue":"2","key":"10.1016\/j.intimp.2026.117386_bb0070","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41423-024-01205-2","article-title":"IL-33 released during challenge phase regulates allergic asthma in an age-dependent way","volume":"22","author":"Liu","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"167","key":"10.1016\/j.intimp.2026.117386_bb0075","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0144-2022","article-title":"Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD","volume":"32","author":"Calderon","year":"2023","journal-title":"Eur. Respir. Rev."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926012336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926012336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:06:15Z","timestamp":1790273175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926012336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":15,"alternative-id":["S1567576926012336"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117386","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic\u2013epigenetic reprogramming of airway fibroblasts by K\u00a0+\u00a0N therapy suppresses IL-33 and ameliorates allergic asthma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117386","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117386"}}